| GANX Stock | | | USD 1.74 0.01 0.58% |
Gain Therapeutics financial indicator trend analysis is much more than just examining Gain Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gain Therapeutics is a good investment. Please check the relationship between Gain Therapeutics Depreciation and its Capital Expenditures accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gain Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Gain Stock please use our
How to Invest in Gain Therapeutics guide.
Depreciation vs Capital Expenditures
Depreciation vs Capital Expenditures Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Gain Therapeutics Depreciation account and
Capital Expenditures. At this time, the significance of the direction appears to have weak relationship.
The correlation between Gain Therapeutics' Depreciation and Capital Expenditures is 0.37. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Gain Therapeutics, assuming nothing else is changed. The correlation between historical values of Gain Therapeutics' Depreciation and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Gain Therapeutics are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Depreciation i.e., Gain Therapeutics' Depreciation and Capital Expenditures go up and down completely randomly.
Correlation Coefficient | 0.37 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Depreciation
Depreciation indicates how much of Gain Therapeutics value has been used up. For tax purposes Gain Therapeutics can deduct the cost of the tangible assets it purchases as business expenses. However, Gain Therapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Capital Expenditures
Capital Expenditures are funds used by Gain Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Gain Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most indicators from Gain Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gain Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gain Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Gain Stock please use our
How to Invest in Gain Therapeutics guide.At this time, Gain Therapeutics'
Tax Provision is fairly stable compared to the past year.
Selling General Administrative is likely to rise to about 11.3
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 3
M in 2024.
Gain Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Gain Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gain Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to
measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.